The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Marketwire

ProMetic to Present at Rodman & Renshaw's Twelfth Annual Healthcare Conference

Thursday, September 09, 2010

ProMetic to Present at Rodman & Renshaw's Twelfth Annual Healthcare Conference16:45 EDT Thursday, September 09, 2010MONTREAL, QUEBEC--(Marketwire - Sept. 9, 2010) - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today announced that Mr. Pierre Laurin, President and Chief Executive Officer, will present at Rodman & Renshaw's Twelfth Annual Healthcare Conference. ProMetic's presentation is scheduled for 12:05 (EDT) on Monday, September 13, 2010. The conference is being held from September 12 - 15, 2010, at the New York Palace Hotel in New York. Details regarding the conference can be obtained at http://www.rodmanrenshaw.com/conferences.Individuals may listen to a live web cast of the presentation by logging on to ProMetic's web site http://www.prometic.com/en/news-events/events.php a few minutes prior to start time to download any necessary software. About ProMetic Life Sciences Inc.ProMetic Life Sciences Inc. (www.prometic.com) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand(TM) technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D facilities in the UK, the U.S. and Canada, manufacturing facilities in the UK and business development activities in the U.S., Europe, Asia and in the Middle-East.FOR FURTHER INFORMATION PLEASE CONTACT: ProMetic Life Sciences Inc. Pierre Laurin President and CEO 514-341-2115 p.laurin@prometic.com or ProMetic Life Sciences Inc. Anne Leduc Manager, Investor Relations & Communications 514-341-2115 a.leduc@prometic.com